Innovative digital solutions tailored for pharmaceutical and biotech companies to accelerate your clinical market strategies with real-world data, patient engagement and digital innovation.
Clinical Development
Enabling safer, smarter and faster trials
Remote Patient Monitoring in your Phase I-II trials: Patient-centricity driving faster, safer & more efficient oncology trials.
Tailored Care Pathways
Enabling Precision Oncology
Design patient-centric programs that boost experience, adherence, and outcomes — while generating real-world, patient-driven insights.
Real-World Evidence
AI-driven, Patient-centric research
Accelerate and de-risk HTA submissions, label expansion, price negotiations, and post-marketing studies by transforming fragmented clinical and patient data into regulatory-grade real-world evidence.
Maximize trial success rate. Accelerate decision making. Strengthen submission package.
- De-risk Phase I–II trials by engaging patients and generating real-time clinical insights aligned with Project Optimus.
- Remote Patient Monitoring reconnecting patients with HCPs, designed for early & weak signal detection
- Increase retention through a BYOD, content-based patient experience. Unique compliance rate to questionnaires (>85% at 12 months)
- Reduce time to insights with real-time longitudinal and high-frequency data to optimize dosing and inform phase III go/no-go decisions
- Compare trial-data with Resilience Real-World Database to demonstrate efficacy and safety vs. SoC
- Provide end-to-end support, from protocol development to data analysis, remaining burdenless for sites, patients and sponsors. Integration with any CRO
Transform patient experience. Support treatment adherence. Improve real-world outcomes.
- Co-create and customize educational and support programs tailored to each indication, product, or specific patient population
- Enhance the patient experience with engaging, clinically validated content co-developed with healthcare professionals
- Improve patient adherence across treatment pathways
- Generate real-world insights and evidence by leveraging symptom and adverse event data for reporting, HEOR, and studies.
- Offer strategic collaboration through joint co-marketing and field team training with your teams and ours.
Accelerate data generation. Leverage multi-dimensional data. Extend partners network.
- Shorten study timelines by 30% thanks to AI-driven EHR-to-EDC extraction and real-time analytics dashboards.
- High-quality evidence at scale — 120+ representative oncology sites, 100 000+ patients by EOY 2026 and 85% weekly PRO compliance.
- Deliver truly patient-centric insights by merging longitudinal EHR data with validated QoL and PRO-CTCAE questionnaires captured in routine care.
- De-risk submissions with RWE that meets FDA/EMA requirements.